Sorin Petre, MD | |
2510 Nw Edenbower Blvd Ste 112, Roseburg, OR 97471-8899 | |
(541) 464-6260 | |
(541) 229-0014 |
Full Name | Sorin Petre |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 34 Years |
Location | 2510 Nw Edenbower Blvd Ste 112, Roseburg, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629037486 | NPI | - | NPPES |
500601705 | Medicaid | OR | |
MD27638 | Other | OR | MEDICAL LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | MD27632 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Medical Center | Roseburg, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Centennial Medical Group Inc | 6103982962 | 46 |
News Archive
Veterans who experienced sexual harassment and assault during military service, known as military sexual trauma, are at higher risk for high blood pressure, according to preliminary research presented today at the American Heart Association's Hypertension Scientific Sessions 2021.
A Supreme Court judge in Melbourne, Australia has described as "high-handed" the delay by global pharmaceutical firm GlaxoSmithKline (GSK) in filing a defence against legal action from Biota Holdings last Friday.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 7 days ago
Entity Name | Centennial Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518103274 PECOS PAC ID: 6103982962 Enrollment ID: O20090303000063 |
News Archive
Veterans who experienced sexual harassment and assault during military service, known as military sexual trauma, are at higher risk for high blood pressure, according to preliminary research presented today at the American Heart Association's Hypertension Scientific Sessions 2021.
A Supreme Court judge in Melbourne, Australia has described as "high-handed" the delay by global pharmaceutical firm GlaxoSmithKline (GSK) in filing a defence against legal action from Biota Holdings last Friday.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Sorin Petre, MD 2801 Nw Mercy Dr Ste 340, Roseburg, OR 97471-2348 Ph: (541) 677-4319 | Sorin Petre, MD 2510 Nw Edenbower Blvd Ste 112, Roseburg, OR 97471-8899 Ph: (541) 464-6260 |
News Archive
Veterans who experienced sexual harassment and assault during military service, known as military sexual trauma, are at higher risk for high blood pressure, according to preliminary research presented today at the American Heart Association's Hypertension Scientific Sessions 2021.
A Supreme Court judge in Melbourne, Australia has described as "high-handed" the delay by global pharmaceutical firm GlaxoSmithKline (GSK) in filing a defence against legal action from Biota Holdings last Friday.
Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.
Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.
› Verified 7 days ago
Dr. Neil Kumar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2410 Nw Edenbower Blvd Ste 176, Roseburg, OR 97471 Phone: 541-957-1133 Fax: 541-957-1799 | |
Bhanu Prasad Paladugu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97470 Phone: 561-677-1773 Fax: 541-677-1794 | |
Kurt A Brickner, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1813 W Harvard Ave, Suite 241, Roseburg, OR 97471 Phone: 541-673-5579 Fax: 541-673-0576 | |
Dr. Luul - Ghebrednghil, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 913 Nw Garden Valley Blvd, Roseburg, OR 97470 Phone: 541-440-1000 Fax: 541-440-1344 | |
Dr. Alpana Chandra, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2460 Nw Stewart Parkway, Suite 103, Roseburg, OR 97471 Phone: 541-672-9515 Fax: 541-464-3177 | |
Siobhan A Oreilly, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 272 Medical Loop, Suite B, Roseburg, OR 97471 Phone: 541-464-5400 Fax: 541-464-5411 | |
Harold F Anderson, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 201, Roseburg, OR 97470 Phone: 541-440-6390 Fax: 541-440-6392 |